Adapting a home telemonitoring intervention for underserved Hispanic/Latino patients with type 2 diabetes: an acceptability and feasibility study.


Journal

BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682

Informations de publication

Date de publication:
07 12 2020
Historique:
received: 09 06 2020
accepted: 22 11 2020
entrez: 8 12 2020
pubmed: 9 12 2020
medline: 12 1 2021
Statut: epublish

Résumé

Home telemonitoring is a promising approach to optimizing outcomes for patients with Type 2 Diabetes; however, this care strategy has not been adapted for use with understudied and underserved Hispanic/Latinos (H/L) patients with Type 2 Diabetes. A formative, Community-Based Participatory Research approach was used to adapt a home telemonitoring intervention to facilitate acceptability and feasibility for vulnerable H/L patients. Utilizing the ADAPT-ITT framework, key stakeholders were engaged over an 8-month iterative process using a combination of strategies, including focus groups and structured interviews. Nine Community Advisory Board, Patient Advisory, and Provider Panel Committee focus group discussions were conducted, in English and Spanish, to garner stakeholder input before intervention implementation. Focus groups and structured interviews were also conducted with 12 patients enrolled in a 1-month pilot study, to obtain feedback from patients in the home to further adapt the intervention. Focus groups and structured interviews were approximately 2 hours and 30 min, respectively. All focus groups and structured interviews were audio-recorded and professionally transcribed. Structural coding was used to mark responses to topical questions in the moderator and interview guides. Two major themes emerged from qualitative analyses of Community Advisory Board/subcommittee focus group data. The first major theme involved intervention components to maximize acceptance/usability. Subthemes included tablet screens (e.g., privacy/identity concerns; enlarging font sizes; lighter tablet to facilitate portability); cultural incongruence (e.g., language translation/literacy, foods, actors "who look like me"); nursing staff (e.g., ensuring accessibility; appointment flexibility); and, educational videos (e.g., the importance of information repetition). A second major theme involved suggested changes to the randomized control trial study structure to maximize participation, including a major restructuring of the consenting process and changes designed to optimize recruitment strategies. Themes from pilot participant focus group/structured interviews were similar to those of the Community Advisory Board such as the need to address and simplify a burdensome consenting process, the importance of assuring privacy, and an accessible, culturally congruent nurse. These findings identify important adaptation recommendations from the stakeholder and potential user perspective that should be considered when implementing home telemonitoring for underserved patients with Type 2 Diabetes. NCT03960424; ClinicalTrials.gov (US National Institutes of Health). Registered 23 May 2019. Registered prior to data collection. https://www.clinicaltrials.gov/ct2/show/NCT03960424?term=NCT03960424&draw=2&rank=1.

Sections du résumé

BACKGROUND
Home telemonitoring is a promising approach to optimizing outcomes for patients with Type 2 Diabetes; however, this care strategy has not been adapted for use with understudied and underserved Hispanic/Latinos (H/L) patients with Type 2 Diabetes.
METHODS
A formative, Community-Based Participatory Research approach was used to adapt a home telemonitoring intervention to facilitate acceptability and feasibility for vulnerable H/L patients. Utilizing the ADAPT-ITT framework, key stakeholders were engaged over an 8-month iterative process using a combination of strategies, including focus groups and structured interviews. Nine Community Advisory Board, Patient Advisory, and Provider Panel Committee focus group discussions were conducted, in English and Spanish, to garner stakeholder input before intervention implementation. Focus groups and structured interviews were also conducted with 12 patients enrolled in a 1-month pilot study, to obtain feedback from patients in the home to further adapt the intervention. Focus groups and structured interviews were approximately 2 hours and 30 min, respectively. All focus groups and structured interviews were audio-recorded and professionally transcribed. Structural coding was used to mark responses to topical questions in the moderator and interview guides.
RESULTS
Two major themes emerged from qualitative analyses of Community Advisory Board/subcommittee focus group data. The first major theme involved intervention components to maximize acceptance/usability. Subthemes included tablet screens (e.g., privacy/identity concerns; enlarging font sizes; lighter tablet to facilitate portability); cultural incongruence (e.g., language translation/literacy, foods, actors "who look like me"); nursing staff (e.g., ensuring accessibility; appointment flexibility); and, educational videos (e.g., the importance of information repetition). A second major theme involved suggested changes to the randomized control trial study structure to maximize participation, including a major restructuring of the consenting process and changes designed to optimize recruitment strategies. Themes from pilot participant focus group/structured interviews were similar to those of the Community Advisory Board such as the need to address and simplify a burdensome consenting process, the importance of assuring privacy, and an accessible, culturally congruent nurse.
CONCLUSIONS
These findings identify important adaptation recommendations from the stakeholder and potential user perspective that should be considered when implementing home telemonitoring for underserved patients with Type 2 Diabetes.
TRIAL REGISTRATION
NCT03960424; ClinicalTrials.gov (US National Institutes of Health). Registered 23 May 2019. Registered prior to data collection. https://www.clinicaltrials.gov/ct2/show/NCT03960424?term=NCT03960424&draw=2&rank=1.

Identifiants

pubmed: 33287815
doi: 10.1186/s12911-020-01346-0
pii: 10.1186/s12911-020-01346-0
pmc: PMC7720574
doi:

Banques de données

ClinicalTrials.gov
['NCT03960424']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

324

Subventions

Organisme : Patient-Centered Outcomes Research Institute (US)
ID : AD-2017C3-9185
Pays : International

Références

Heart Lung. 2001 May-Jun;30(3):191-9
pubmed: 11343005
Womens Health Issues. 2007 May-Jun;17(3):150-61
pubmed: 17475506
Diabetes Care. 2010 Aug;33(8):1712-7
pubmed: 20484125
Educ Health (Abingdon). 2001;14(2):182-97
pubmed: 14742017
Stat Med. 1990 Jun;9(6):645-56
pubmed: 2218168
Sci Rep. 2017 Oct 4;7(1):12680
pubmed: 28978949
Fam Syst Health. 2014 Mar;32(1):78-88
pubmed: 24079815
Diabetes Care. 2009 Jun;32(6):1115-8
pubmed: 19460917
CMAJ. 2017 Mar 6;189(9):E341-E364
pubmed: 27799615
Ann Intern Med. 1996 Aug 1;125(3):221-32
pubmed: 8686981
Diabetes Care. 1998 Aug;21(8):1230-5
pubmed: 9702425
Diabetologia. 2012 Jun;55(6):1577-96
pubmed: 22526604
Ethn Dis. 2013 Autumn;23(4):401-8
pubmed: 24392600
PLoS One. 2017 Mar 1;12(3):e0173160
pubmed: 28249025
JAMA. 2002 May 15;287(19):2519-27
pubmed: 12020332
Diabetes Educ. 2017 Feb;43(1):54-77
pubmed: 28118127
Health Promot Pract. 2006 Jul;7(3):312-23
pubmed: 16760238
Diabetes Care. 2018 Jan;41(Suppl 1):S7-S12
pubmed: 29222372
Ethn Health. 2013;18(1):83-96
pubmed: 22762449
Diabetes Obes Metab. 2009 Oct;11(10):913-30
pubmed: 19531058
J Natl Med Assoc. 2002 Aug;94(8):666-8
pubmed: 12152921
Diabetes Res Clin Pract. 2016 Jun;116:136-48
pubmed: 27321329
Lancet Diabetes Endocrinol. 2014 Nov;2(11):867-74
pubmed: 25128274
Arch Intern Med. 2007 Sep 24;167(17):1853-60
pubmed: 17893306
Diabetes Care. 2003 Feb;26(2):495-501
pubmed: 12547888
J Med Internet Res. 2016 Sep 26;18(9):e256
pubmed: 27670360
N Engl J Med. 1989 Oct 19;321(16):1074-9
pubmed: 2797067
Health Soc Care Community. 2012 Jan;20(1):1-19
pubmed: 21749529
Prog Community Health Partnersh. 2010 Summer;4(2):131-40
pubmed: 20543488
JMIR Form Res. 2020 Jan 31;4(1):e13197
pubmed: 32012039
Health Promot Pract. 2005 Jul;6(3):286-98
pubmed: 16020623
Contemp Clin Trials. 2009 Jan;30(1):47-54
pubmed: 18775798
Int J Telemed Appl. 2012;2012:715194
pubmed: 22997511
ANS Adv Nurs Sci. 2004 Jul-Sep;27(3):162-75
pubmed: 15455579
Medicine (Baltimore). 2018 Oct;97(43):e12962
pubmed: 30412116
AIDS Educ Prev. 2014 Oct;26(5):383-97
pubmed: 25299804
J Am Med Inform Assoc. 2009 Jul-Aug;16(4):446-56
pubmed: 19390093
PLoS One. 2013 Nov 08;8(11):e79246
pubmed: 24250826
J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S40-6
pubmed: 18301133

Auteurs

Renee Pekmezaris (R)

Department of Medicine, Division of Health Services Research, Northwell Health, Manhasset, NY, USA. Rpekmeza@northwell.edu.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA. Rpekmeza@northwell.edu.
Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA. Rpekmeza@northwell.edu.
Center for Health Innovations and Outcomes Research, Northwell Health, Manhasset, NY, USA. Rpekmeza@northwell.edu.

Myia S Williams (MS)

Department of Medicine, Division of Health Services Research, Northwell Health, Manhasset, NY, USA.
Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.
Center for Health Innovations and Outcomes Research, Northwell Health, Manhasset, NY, USA.

Briana Pascarelli (B)

Department of Medicine, Division of Health Services Research, Northwell Health, Manhasset, NY, USA.
Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.
Center for Health Innovations and Outcomes Research, Northwell Health, Manhasset, NY, USA.

Kayla D Finuf (KD)

Department of Medicine, Division of Health Services Research, Northwell Health, Manhasset, NY, USA. KFinuf@northwell.edu.
Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA. KFinuf@northwell.edu.
Center for Health Innovations and Outcomes Research, Northwell Health, Manhasset, NY, USA. KFinuf@northwell.edu.

Yael T Harris (YT)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Department of Medicine, Division of Endocrinology, North Shore University Hospital, Manhasset, NY, USA.

Alyson K Myers (AK)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.
Center for Health Innovations and Outcomes Research, Northwell Health, Manhasset, NY, USA.
Department of Medicine, Division of Endocrinology, North Shore University Hospital, Manhasset, NY, USA.

Tonya Taylor (T)

College of Medicine, Division of Infectious Disease, SUNY-Downstate Health Sciences University, Brooklyn, NY, USA.

Myriam Kline (M)

Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.

Vidhi H Patel (VH)

Department of Medicine, Division of Health Services Research, Northwell Health, Manhasset, NY, USA.
Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.
Center for Health Innovations and Outcomes Research, Northwell Health, Manhasset, NY, USA.

Lawrence M Murray (LM)

Annie E. Casey Foundation Children and Family Fellowship, Baltimore, MD, USA.

Samy I McFarlane (SI)

Department of Medicine, SUNY-Downstate Health Sciences University, Brooklyn, NY, USA.

Karalyn Pappas (K)

Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.

Martin L Lesser (ML)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.

Amgad N Makaryus (AN)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Department of Cardiology, Nassau University Medical Center, East Meadow, NY, USA.

Sabrina Martinez (S)

Center for Health Innovations and Outcomes Research, Northwell Health, Manhasset, NY, USA.

Andrjez Kozikowski (A)

Department of Medicine, Division of Health Services Research, Northwell Health, Manhasset, NY, USA.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.
Center for Health Innovations and Outcomes Research, Northwell Health, Manhasset, NY, USA.

Jennifer Polo (J)

Northwell Health, Manhasset, NY, USA.

Josephine Guzman (J)

Northwell Health, Manhasset, NY, USA.

Roman Zeltser (R)

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Nassau University Medical Center, East Meadow, NY, USA.

Jose Marino (J)

Center for Health Innovations and Outcomes Research, Northwell Health, Manhasset, NY, USA.

Maria Pena (M)

Nassau University Medical Center, East Meadow, NY, USA.
Mount Sinai Hospital, Mount Sinai Health System, New York, NY, USA.

Ralph J DiClemente (RJ)

Department of Social and Behavioral Sciences, NYU School of Global Public Health, New York, NY, USA.

Dilcia Granville (D)

Hispanic Counseling Center, Hempstead, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH